| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/19/1999 | US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861158 Improving a transplantation of hematopoietic cells from a donor to a recipient |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | CA2131231C Salmonella live vaccine |
| 01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
| 01/19/1999 | CA2013573C Vaccines containing avirulent phop-type microorganisms |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/18/1999 | CA2237786A1 Novel aroa |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237049A1 Novel ratc |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/17/1999 | CA2237162A1 Novel glucose kinase |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
| 01/14/1999 | WO1999001473A2 Anti-bacterial methods and materials |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001465A1 A senescence gene and its use in the treatment of cancer and other diseases |
| 01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001158A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | WO1999001153A1 Rio mamore hantavirus |
| 01/14/1999 | WO1999001115A1 Colon selective drug delivery composition |
| 01/14/1999 | WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides |
| 01/14/1999 | WO1998049314A3 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 01/14/1999 | WO1998049313A3 Characterization of granulocytic ehrlichia and methods of use |
| 01/14/1999 | WO1998044096A3 Mycobacterium recombinant vaccines |
| 01/14/1999 | WO1998040097A3 Bovine respiratory and enteric coronavirus as a vaccine |
| 01/14/1999 | WO1998039029A3 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof |
| 01/14/1999 | CA2295933A1 Compounds and methods for treating and screening viral reactivation |
| 01/14/1999 | CA2295376A1 Anti-bacterial methods and materials |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294793A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | CA2294702A1 Mammalian secretory peptide-9 |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890643A2 25-Hydroxyvitamin D3-1a-hydroxylase and dna encoding the hydroxylase |
| 01/13/1999 | EP0890642A2 Retrovirus of the HIV-group and its application |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0890578A2 Polynucleotides encoding human clock gene and their use |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889907A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889736A1 Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 01/13/1999 | EP0889735A1 Immunological methods for the treatment of gastrointestinal cancer |
| 01/13/1999 | EP0889734A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | CN1205033A Method for obtaining microorganism capable of producing antibumor molecules |
| 01/13/1999 | CN1205012A Urogenital carcinoma TLP complex peptides and antibodies thereof |
| 01/12/1999 | US5859226 Nucleotide sequences which suppress immune response by reducing major histocompatibility/human leukocyte antigen gene expression; for transplantation, autoimmune diseases, hepatitis b and cytomegalovirus infections |
| 01/12/1999 | US5859225 Virion protein 26 from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859196 P30 peptides of Toxoplasma gondii |
| 01/12/1999 | US5859193 Synthetic DNA derived recombinant HIV antigens |
| 01/12/1999 | US5859189 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 01/12/1999 | US5859187 Inhibit the ul42 stimulation of the herpes virus dna polymerase activity |
| 01/12/1999 | US5859185 HCMV-specific peptides, agents therefor and the use thereof |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858989 Veterinary medicine |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858980 Peptide fragments of myelin basic protein |
| 01/12/1999 | US5858968 Autoimmune model: insulin not used for its endocrinologic effect (does not affect blood sugar levels), but to damp down the host's autoimmune response and prevent autoimmune destruction of pancreatic beta cells, allowing oral dosing |
| 01/12/1999 | US5858963 Inducing xenograft tolerance and porcine cytokines therefor |
| 01/12/1999 | US5858838 Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858780 Cisplatin resistant cell line |
| 01/12/1999 | US5858776 Tumor cells with increased immunogenicity and uses therefor |
| 01/12/1999 | US5858775 Adeno-associated virus materials and methods |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858729 Preparation of glycosylated open reading frames 3 and 4 of protein associated with mystery swine disease, by co-infecting, culturing, harvesting eukaryotic cells with subgenomic dna fragments in viral vectors |
| 01/12/1999 | US5858727 Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms |
| 01/12/1999 | US5858726 Plasmid dna vectors for expression of viral capsid polypeptides and envelope glycoproteins from different virus species; producing self-assembling, non-replicating, non-infectious particles for vaccine and drug therapy |
| 01/12/1999 | US5858720 Hiss |
| 01/12/1999 | US5858719 Polynucleotides encoding human ATP binding-cassette transport protein and methods of use |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858710 Tumor-associated kazal inhibitor-like polypeptides and encoding polynucleotides |
| 01/12/1999 | US5858709 Fibronectin binding protein B compounds |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |